Home Newsletters Hepatic Cell News ECM1 Modified HF-MSCs Targeting HSC Attenuate Liver Cirrhosis by Inhibiting the TGF-β/Smad...

ECM1 Modified HF-MSCs Targeting HSC Attenuate Liver Cirrhosis by Inhibiting the TGF-β/Smad Signaling Pathway

0
To improve the effectiveness of naïve hair follicle-derived-MSC (HF-MSC) treatments on liver cirrhosis (LC), the authors used bioinformatic tools to identify an exogenous gene targeting hepatic stellate cells (HSCs) among the differentially expressed genes in LC to modify HF-MSCs.
[Cell Death Discovery]
7992332 {7992332:BBBBBBBB} apa 50 1 171576 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version